Positivity Rate of Autologous Plasma Skin Test and Autologous Serum Skin Test in Chronic Spontaneous Urticaria
Keywords:
chronic spontaneous urticaria, screening test, autologous plasma skin test, autologous serum skin test, urticaria activity scoreAbstract
Background: Autologous plasma skin test (APST) and autologous serum skin test (ASST) are simple, semi-invasive, inexpensive, and easy to perform diagnostic test for chronic spontaneous urticaria (CSU). However, the positivity rate of both tests was varied. The study aims to compare the positivity rate of APST and ASST in patients with CSU, and correlate with urticaria activity. Method: This study included 36 CSU patients underwent testing with APST and ASST. Urticaria activity was assessed by urticaria activity score over 7 days (UAS7). We observed positivity APST and ASST among moderate-severe and mild urticaria activity Result: Twenty-two of 36 CSU patients was female, with mean age was 28± 9.969 years old. The positivity rate of APST was higher than ASST (83.33% vs 66.67%). Positive APST with negative ASST were 25%, meanwhile negative APST with positive ASST were 8.33%. Not only were no statistically significant differences in APST and ASST, but also age, sex, and ASST diameter with urticaria activity (p = 0,378, p = 0.968, p = 1.000, p = 0.826, respectively). The positiveness rates of APST were significantly higher in the patient with moderate-severe activity than mild activity (p = 0.008). Conclusion: In conclusion, positivity rate of APST was higher than ASST among patients with CSU. Furthermore, positivity APST was associated with moderate-severe urticaria activity, and may considered as a screening test to predict urticaria activity in CSU patients.References
Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734–66.
Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M. Autoimmune chronic spontaneous urticaria: What we know and what we do not know. J Allergy Clin Immunol. 2017;139(6):1772–81.
Curto-Barredo L, Riba Archilla L, Roura Vives G, Pujol RM, Giménez-Arnau AM. Clinical features of chronic spontaneous urticaria that predict disease prognosis and refractoriness to standard treatment. Acta Derm Venereol. 2018;98(7):641–7.
Lapi F, Cassano N, Pegoraro V, Cataldo N, Heiman F, Cricelli I, et al. Epidemiology of chronic spontaneous urticaria: Results from a nationwide, population-based study in Italy. Br J Dermatol. 2016;174:996–1004.
Chu CY, al Hammadi A, Agmon-Levin N, Atakan N, Farag A, Arnaout RK, et al. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H1-Antihistamines in Asia, Middle-East and Africa: Results from the AWARE-AMAC study. World Allergy Organ J. 2020;13(4).
Alpay A, Solak Tekin N, Tekin IÖ, Altinyazar HC, Koca R, Çnar S. Autologous serum skin test versus autologous plasma skin test in patients with chronic spontaneous urticaria. Dermatol Res Pract. 2013;2013.
Baig SA, Balachandran C, Nayak US. Comparative evaluation of autologous serum skin test and autologous plasma skin test in chronic urticaria. J Pakistan Assoc Dermatologists. 2013;23(4):378–83.
Ismail R, Jamil A, Nor N, Bakhtiar M. A comparison of autologous serum, plasma, and whole blood for intradermal autoreactivity testing in patients with chronic spontaneous urticarial: A cross-sectional study. J Dermatol Dermatol Surg. 2022;26(1):6.
Niu X, Zhu L, Shi M, Zhang Y, Gao X, Qi R. Association of positive and negative autologous serum skin test responses with clinical features of chronic spontaneous urticaria in Asian patients: A systematic review and meta analysis. Exp Ther Med. 2019;17:2603–13.
Cugno M, Marzano A v, Asero R, Tedeschi A. Activation of blood coagulation in chronic urticaria: Pathophysiological and clinical implications. Intern Emerg Med. 2010;5:97–101.
Kumaran M, Mangal S, Narang T, Parsad D. Autologous serum and plasma skin tests in chronic spontaneous urticaria: A reappraisal. Indian Dermatol Online J. 2017;8:94–9.
Dogheim N, Gheida S, Ghaly N, Ibrahim A, El-Enin A. Chronic idiopathic urticaria: autologous skin tests and treatment. Egyptian J Dermatol Venereol. 2014;34(1):46–52.
Boonpiyathad T, Sangasapaviliya A. Autologous serum and plasma skin test to predict 2-year outcome in chronic spontaneous urticaria. Asia Pac Allergy. 2016;6(4):226–35.
Nopriyati N, Thaha A, Tjekyan S. Hubungan autologous serum skin test/ASST dengan keparahan klinis urtikaria kronik idiopatik di RSUP Dr. Moh Hoesin Palembang. MAKARA J Heal Res. 2008;12(1):27–35.
Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol. 2006;117(5):1113–7.
Aktar S, Akdeniz N, Ozkol HU, Calka O, Karadag AS. The relation of autologous serum and plasma skin test results with urticarial activity score, sex and age in patients with chronic urticaria. Postep Derm Alergol. 2015;32(3):173–8.
Sajedi V, Movahedi M, Aghamohamadi A, Ghareguzlou M, Shafiei A, Soheili H, et al. Comparison between sensitivity of autologous skin serum test and autologous plasma skin test in patients with chronic idiopathic urticaria for detection of antibody against IgE or IgE receptor (FcεRIα). Iran J Allergy Asthma Immunol. 2011;10(2):111–7.
Thadanipon K, Wattanakrai P. Comparison between autologous serum skin test and autologous plasma skin test in Thai chronic urticaria patients. J Med Assoc Thai. 2017;100(9):1014–20.
